<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Pharmacol Exp Ther</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Pharmacol. Exp. Ther</journal-id>
<journal-id journal-id-type="hwp">jpet</journal-id>
<journal-id journal-id-type="pmc">J Pharmacol Exp Ther</journal-id>
<journal-id journal-id-type="publisher-id">JPET</journal-id>
<journal-title-group>
<journal-title>The Journal of Pharmacology and Experimental Therapeutics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0022-3565</issn>
<issn pub-type="epub">1521-0103</issn>
<publisher>
<publisher-name>The American Society for Pharmacology and Experimental Therapeutics</publisher-name>
<publisher-loc>Bethesda, MD</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27789681</article-id>
<article-id pub-id-type="pmc">5193073</article-id>
<article-id pub-id-type="publisher-id">JPET_237412</article-id>
<article-id pub-id-type="doi">10.1124/jpet.116.237412</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Minireviews</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Estrogen Signaling as a Therapeutic Target in Neurodevelopmental Disorders</article-title>
<alt-title alt-title-type="short">Estrogen Signaling, ASD, and Schizophrenia</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Crider</surname>
<given-names>Amanda</given-names>
</name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Pillai</surname>
<given-names>Anilkumar</given-names>
</name>
</contrib>
<aff id="aff1">Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta University, Augusta, Georgia</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><bold>Address correspondence to:</bold> Dr. Anilkumar Pillai, <addr-line>CA-3143, 1462 Laney Walker Blvd, Augusta University, Augusta, GA 30912</addr-line>. E-mail: <email>apillai@augusta.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>1</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<month>1</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>1</day>
<month>1</month>
<year>2018</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>360</volume>
<issue>1</issue>
<fpage>48</fpage>
<lpage>58</lpage>
<history>
<date date-type="received">
<day>23</day>
<month>8</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>10</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright Â© 2016 by The American Society for Pharmacology and Experimental Therapeutics</copyright-statement>
<copyright-year>2017</copyright-year>
</permissions>
<self-uri xlink:href="jpet.116.237412.pdf" xlink:title="pdf" xlink:type="simple"></self-uri>
<abstract>
<p>Estrogens, the primary female sex hormones, were originally characterized through their important role in sexual maturation and reproduction. However, recent studies have shown that estrogens play critical roles in a number of brain functions, including cognition, learning and memory, neurodevelopment, and adult neuroplasticity. A number of studies from both clinical as well as preclinical research suggest a protective role of estrogen in neurodevelopmental disorders including autism spectrum disorder (ASD) and schizophrenia. Alterations in the levels of estrogen receptors have been found in subjects with ASD or schizophrenia, and adjunctive estrogen therapy has been shown to be effective in enhancing the treatment of schizophrenia. This review summarizes the findings on the role of estrogen in the pathophysiology of neurodevelopmental disorders with a focus on ASD and schizophrenia. We also discuss the potential of estrogen as a therapeutic target in the above disorders.</p>
</abstract>
<counts>
<fig-count count="1"></fig-count>
<table-count count="1"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="199"></ref-count>
<page-count count="11"></page-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name> DJS Export </meta-name>
<meta-value>v1</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</article>
</pmc-articleset>